Clinical trials
Diabetes (Insulin-requiring, Type 1 or Type 2) clinical trials
Below are recruiting diabetes (insulin-requiring, type 1 or type 2) clinical trials, each written for real people, not researchers. We’re tracking 2,190 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07481747RecruitingPhase 3
Weekly injection for weight loss in adults with obesity
This trial tests a once-weekly injection (tirzepatide) versus a placebo to help people who are obese or overweight with related health conditions lose weight. You may qualify if you have tried to lose weight through diet before, but have not been successful.
Shenzhen, GuangdongAges 18 years+ - NCT07673822Enrolling by invitation
Heart, kidney, and metabolic disease study in Korea
This study looks at how common heart, kidney, and metabolic problems are in Korea by using health insurance records. It will help doctors understand how often these conditions happen together.
SeoulAges 19 years+ - NCT07495020Recruiting
Weight loss surgery study for type 2 diabetes
This study tests a new type of weight loss surgery for people with type 2 diabetes and a body mass index (BMI) between 25 and 35. The surgery uses a clip and a special stitch to help with weight loss and diabetes control.
AstanaAges 18–65 - NCT07495787Recruiting
Magnets to connect parts of small intestine for type 2 diabetes
This study tests a new procedure that uses magnets to connect two sections of your small intestine. It aims to see if this approach can help improve blood sugar control and aid in weight management for people with type 2 diabetes who currently take oral medications.
Ahmedabad, GujaratAges 25–65 - NCT07521631RecruitingPhase 2
HDM1005 versus Tirzepatide for weight management in obese adults
This study tests whether a new injectable medication called HDM1005 works as well as tirzepatide (a GLP-1 drug) for weight loss in adults with obesity but no diabetes. Both medications work similarly in the body to help control appetite and weight.
ShanghaiAges 18–65 - NCT07542834Recruiting
Virtual Reality Training for Medical Students
This study tests whether using virtual reality can help medical students learn better and feel more confident in their training. Researchers will compare how students learn with VR versus traditional methods.
Athens, OhioAges 18 years+ - NCT07570992RecruitingPhase 1
Safety study of NNC1679-0001 in healthy people and people with type 2 diabetes
This study tests the safety of a new medicine called NNC1679-0001 in healthy adults and those with type 2 diabetes. The goal is to see if it is safe before larger trials.
GrazAges 18–64 - NCT07588438RecruitingPhase 4
Tirzepatide effectiveness and safety for diabetes and weight loss in Paraguay
This study tests how well and safely tirzepatide (a new injectable medication) works in real-world conditions for people with type 2 diabetes or obesity in Paraguay. The medication helps lower blood sugar and reduce weight.
AsunciónAges 18–70 - NCT07588503RecruitingPhase 1
FES Cycling With Blood Flow Restriction for Spinal Cord Injury
This study tests a new exercise method combining electrical stimulation (FES) and controlled blood flow restriction while you cycle. It's designed to improve heart health, blood sugar control, and fitness in people with spinal cord injuries.
Toronto, OntarioAges 18–75 - NCT07595718Recruiting
AI Study of Disease Patterns and Health Data
This research uses artificial intelligence to analyze health information from adults to better understand and predict when major diseases like diabetes, heart disease, and cancer might develop. Your participation could help scientists discover new patterns that improve early detection.
Seoul, Seoul Special CityAges 30–60 - NCT07632677Recruiting
Testing a liver inflammation score in diabetes and fatty liver
This study tests whether a new scoring method can help doctors identify liver inflammation in patients who have both type 2 diabetes and a fatty liver. The goal is to find an easier, safer way to assess liver health without invasive procedures.
Bengbu, AnhuiAges 18 years+ - NCT07636395Recruiting
How obesity medication affects your eating habits
This study tracks how your eating behavior changes when you take obesity medication. Researchers want to understand what happens to your appetite and food choices before, during, and after treatment to help improve how these medications work.
DublinAges 16–80 - NCT07264062Enrolling by invitation
MetSense pilot study for serious mental illness
This pilot study is testing a program for people with serious mental illness like schizophrenia or bipolar disorder. It aims to see if adding a special monitoring tool helps manage treatment better.
Pleasanton, CaliforniaAges 18 years+ - NCT07209527Enrolling by invitationEarly Phase 1
Truway diagnostic tools in primary care
This trial tests new diagnostic tools that doctors can use in primary care. Researchers want to see if these tools help find the right diagnosis faster and more accurately.
New York, New YorkAges Any age - NCT06923735Enrolling by invitation
Nutrition app pilot for employee health checks
This pilot study tests a nutrition app to help employees manage conditions like high cholesterol, high blood pressure, weight issues, or type 2 diabetes. It is part of your regular occupational health check or dietitian visit.
KuopioAges 18–75 - NCT06845345Enrolling by invitationPhase 4
Can a special diet or pills help liver health?
This study compares two treatments for liver scarring in people with overweight or related health issues. One group follows a special diet with restricted eating times, while the other takes a combination of two medications (naltrexone and bupropion). It aims to see which approach better improves liver fibrosis.
RotterdamAges 18–75 - NCT06831162Enrolling by invitation
Study on addressing health needs in diabetes care
This study looks at whether connecting people with type 2 diabetes, along with high blood pressure or high cholesterol, to resources for needs like food or housing can improve their health. It uses information from a screening questionnaire and may ask some patients to complete a survey.
Nashville, TennesseeAges 18 years+ - NCT06828549Enrolling by invitation
Mobile support for diabetes tailored to your needs
This study tests a mobile health program designed to help people with type 2 diabetes manage their condition better. You and a support person (like a family member or friend) will use your phones to get reminders, tips, and encouragement.
Birmingham, AlabamaAges 18–75 - NCT06768177Enrolling by invitation
Platelet-Rich Plasma for Erectile Dysfunction
This trial tests if injecting platelet-rich plasma (PRP) into the penis can improve erectile function in men who haven't had success with other treatments. It may be an option if you have moderate to severe ED, have tried other therapies, or have had pelvic surgery.
BariAges 30 years+ - NCT06709040Enrolling by invitation
Long-term safety of somapacitan in children with growth hormone deficiency
This study is watching children who are already taking somapacitan (a growth hormone injection) to see if it is safe over a long time. It collects information about growth and any side effects.
Glasgow, ScotlandAges Up to 18 years - NCT06533007Enrolling by invitation
How PDE3B affects metabolism in healthy adults
This study looks at how a protein called PDE3B affects your body's metabolism (how it uses energy). It may help researchers understand weight and insulin resistance better, which could lead to new treatments.
CambridgeAges 21–75 - NCT06519448Enrolling by invitation
Testing a pill for non-alcoholic fatty liver disease
This trial tests a diabetes drug called empagliflozin to see if it can reduce fat and inflammation in the liver in people with a specific type of fatty liver disease called NASH. It may help if you have NASH and either have type 2 diabetes or don't have it.
PragueAges 18–75 - NCT06330480Enrolling by invitation
Screening for heart rhythm and kidney disease at home
This study is testing whether screening people at home can catch early signs of an irregular heartbeat (atrial fibrillation) and kidney disease. If you're in the right age group and live in one of the selected regions, you could join and help researchers learn more about spotting these conditions early.
AmsterdamAges 50–75 - NCT05766488Enrolling by invitation
Testing continuous glucose monitor use in type 2 diabetes care
This study checks whether using a continuous glucose monitor (CGM, a sensor that tracks blood sugar) is practical and helpful for people with type 2 diabetes in primary care settings. It focuses on people who may have a harder time getting diabetes support and have higher A1c levels.
Omaha, NebraskaAges 19 years+
Hear when a new Diabetes (Insulin-requiring, Type 1 or Type 2) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes (insulin-requiring, type 1 or type 2)?
- Yes. Clin2 currently lists 2,190 recruiting diabetes (insulin-requiring, type 1 or type 2) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes (insulin-requiring, type 1 or type 2) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes (insulin-requiring, type 1 or type 2) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.